Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Vincent Rajkumar Mayo Clinic FDA Oncology Myeloma Society
oncodaily.com/58145.html

#Cancer #Cancer Treatment #DrugApprovals #ClinicalTrials #FDA #OncoDaily #Oncology #PatientCare

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients | Leukemia nature.com/articles/s4137…

Join us at #IMS2024 in Rio de Janeiro, Brazil, from September 25-28 for an unforgettable experience filled with learning and discussion. Don't miss out! Register now➡️rb.gy/1h136x

And wonderful to see another super ⭐️ Megan Melody MD, MS 👏Northwestern Hematology/Oncology Fellowship #HOPLive24

Every #myeloma therapy option comes with potential benefits and potential risks that your doctor will help you better understand. Read more on several treatment options: mymyelomateam.com/resources/weig…

International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of TCE bispecific antibodies in MM #mmsm The Lancet Oncology Paula Rodriguez-Otero Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Jonathan Kaufman, MD Rakesh Popat thelancet.com/journals/lanon…

TOMORROW!🗓 Myeloma Roundtable in Charlotte, NC. Are you coming? Register here: buff.ly/3W1ylCE Luciano J Costa Dr.MHB

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

Myeloma Paper of the Day, May 2nd, suggested by Robert Z. Orlowski
Ieuan Walker
oncodaily.com/60480.html

#Cancer #Myeloma #OncoDaily #Oncology #Cancer Research

Did you know that #MRD is much more precise and accurate than other tests? After remission, it helps predict how likely a #relapse of #myeloma is. Learn more: mymyelomateam.com/resources/what…

Myeloma Paper of the Day, May 1st, suggested by Robert Z. Orlowski
iScience journal OHSU Knight Cancer Institute
oncodaily.com/60192.html

#Cancer #MM #MyelomaPaperOfTheDay #OncoDaily #Oncology #P53 #Cancer Research

#Myeloma Paper of the Day: Combining surface proteomics with computational approaches to design NOT gated CAR T-cells that are down-regulated when an inhibitory CAR is bound by a normal tissue antigen to expand the target repertoire in #myeloma : pubmed.ncbi.nlm.nih.gov/38688994/.

#Myeloma Paper of the Day: Study of ubiquitin-specific protease 7 inhibitors reveals a different mechanism of action vs. MDM2 inhibitors and shows anti-cancer activity in pre-clinical in vitro and in vivo models of #myeloma : pubmed.ncbi.nlm.nih.gov/38689642/.

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

Myeloma Paper of the Day, April 30th, suggested by Robert Z. Orlowski
MD Anderson Cancer Center Blood Cancer Journal Paula Rodriguez-Otero PETHEMA
oncodaily.com/59340.html

#Cancer #MM #MyelomaPaperOfTheDay #OncoDaily #Oncology #Cancer Research

Special thank you to my 54 new followers from USA, Armenia, India, and more last week. fedica.com/!Myeloma_Doc

#Myeloma Paper of the Day: Genomic profiling of high-risk SMM patients who got intensive tx shows DIS3, FAM46C, FGFR3 muts, t(4;14) & 1q alterations enriched in HR SMM, NRAS mutations & co-occurrence t(4;14)/FGFR3 muts assoc. w/ increased progression: pubmed.ncbi.nlm.nih.gov/38684670/.

Our annual impact report has arrived!🙌🥳 This impact wouldn’t have been possible without YOU.❤️ Learn how our research initiatives & investment in new promising therapies are helping to advance a cure for each & every #myeloma patient. Download your copy: ow.ly/5NLm50Rpneb

Myeloma Paper of the Day, April 29th, suggested by Robert Z. Orlowski
MD Anderson Cancer Center Chiara Montironi
oncodaily.com/58428.html

#Cancer #GlutamineDeprivation #Myeloma #OncoDaily #Oncology

To achieve #HepatitisElimination globally we need to collaborate with colleagues and allied professionals from other countries like the European Study Group for Viral Hepatitis. #HepB #HepC ESCMID IDSA CDC Hepatitis EASLnews AASLD #ECCMID2024 #ESCMIDGlobal World Health Organization (WHO)